Indications : התוויות

Therapeutic indications:                                        during two to four months following treatment to detect, at        Due to a potential increase of bone marrow suppression,           effects of a therapy with cladribine. Tumor lysis syndrome as
• Hairy cell leukaemia                                              an early stage, potential hematological side effects (anemia,      cladribine should not be used concomitantly with other            well as transfusion-related graft-versus-host-disease have
• Chronic lymphocytic leukaemia                                     neutropenia, thrombocytopenia) as well as infections,              myelosuppressive medicinal products.                              been reported in very rare cases.
• Second line treatment for low grade Non-Hodgkin’s                 hemolysis or bleedings at an early stage, and to monitor           Due to the similar intracellular metabolism, cross-resistance     Infections and infestations lymphoma                                                          hematological recovery.                                            with other nucleoside analogs, such as fludarabine, may           Very common: Infections (27%-58%)
Patients with a manifestation of bone marrow depression            occur. Therefore, simultaneous administration of nucleoside